1. Home
  2. HIW vs VERA Comparison

HIW vs VERA Comparison

Compare HIW & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HIW

Highwoods Properties Inc.

N/A

Current Price

$21.61

Market Cap

2.5B

Sector

Real Estate

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$38.74

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIW
VERA
Founded
1978
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
HIW
VERA
Price
$21.61
$38.74
Analyst Decision
Hold
Strong Buy
Analyst Count
8
10
Target Price
$29.50
$80.56
AVG Volume (30 Days)
1.6M
886.2K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
9.03%
N/A
EPS Growth
54.26
N/A
EPS
1.45
N/A
Revenue
$806,112,000.00
N/A
Revenue This Year
$6.91
N/A
Revenue Next Year
$3.49
$445.28
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.56
$18.53
52 Week High
$32.76
$56.05

Technical Indicators

Market Signals
Indicator
HIW
VERA
Relative Strength Index (RSI) 31.87 34.71
Support Level $21.56 $19.84
Resistance Level $23.68 $56.05
Average True Range (ATR) 0.67 1.70
MACD -0.02 -0.24
Stochastic Oscillator 16.19 11.06

Price Performance

Historical Comparison
HIW
VERA

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a fully integrated office REIT that owns, develops, acquires, leases, and manages office properties mainly in the best business districts of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond, and Tampa. Its principal business is the operation, acquisition, and development of rental office properties, with no material inter-segment transactions. The Company evaluates performance by geographic location, and the operating results by geographic grouping are regularly reviewed by the chief operating decision maker. The core portfolio consists mainly of office properties in its key markets, with the majority of revenue derived from its Raleigh properties.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: